Currently out of the existing stock ratings of Sachin Jain, 1 are a HOLD (5.56%), 16 are a BUY (88.89%), 1 are a SELL (5.56%).

Sachin Jain

Work Performance Price Targets & Ratings Chart

Analyst Sachin Jain, currently employed at BAML, carries an average stock price target met ratio of 75% that have a potential upside of 39.89% achieved within 674 days. Previously, Sachin Jain worked at DEUTSCHE BANK.

Sachin Jain’s has documented 27 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 25-Nov-2025.

Wall Street Analyst Sachin Jain

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC ADR) at 9/29/2021. The price target of $138.8 was fulfilled within 561 days with a profit of $31.24 (29.04%) receiving and performance score of 0.52.

Average potential price target upside

AZN AstraZeneca PLC ADR NVO Novo Nordisk A/S

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Dec-2019

$105

$-83.41 (-44.27%)

$95

9 months 25 days ago
(09-Dec-2025)

0/13 (0%)

$-72.77 (-40.93%)

Buy Since 05-Sep-2023

$108.5

$-79.91 (-42.41%)

$91.7

10 months 9 days ago
(25-Nov-2025)

1/6 (16.67%)

$-76.04 (-41.21%)

483

Hold Since 27-Oct-2025

11 months 7 days ago
(27-Oct-2025)

3/6 (50%)

$14.33 (11.16%)

782

Buy Since 30-May-2024

$97

1 years 6 months 4 days ago
(30-Mar-2025)

0/2 (0%)

$-43.8 (-31.11%)

Hold Since 12-Feb-2025

1 years 7 months 22 days ago
(12-Feb-2025)

7/11 (63.64%)

$120.33 (100.53%)

675

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Sachin Jain?

On 2014
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?